Value is all about what a company is worth versus what price it is
available for. If you went into a grocery store and all the bananas were on sale
at half price, they could be considered
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
It is not possible to calculate the future cash flow value for
TerrAscend. This is due to cash flow or dividend data being
unavailable. The share price is
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for
it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing
when they are out of season, or how much your home is worth.
The amount the stock market is willing to pay for
is considered below, and whether this is a fair price.
Price based on past earnings
TerrAscend's earnings available for a low price, and how does
this compare to other companies in the same industry?
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as TerrAscend has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by Simply Wall St do have past financial data. You can see them here.
Show me the analysis anyway
The future performance of a company is measured in the same way as past
performance, by looking at estimated
and how much profit it is expected to make.
Future estimates come from
professional analysts. Just like forecasting the weather, they don’t always get
Expected Pharmaceuticals industry annual growth in earnings.
Earnings growth vs Low Risk Savings
expected to grow at an
Unable to compare TerrAscend's earnings growth to the low risk savings rate as no estimate data is available.
Growth vs Market Checks
Unable to compare TerrAscend's earnings growth to the Canada market average as no estimate data is available.
Unable to compare TerrAscend's revenue growth to the Canada market average as no estimate data is available.
Unable to determine if TerrAscend is high growth as no earnings estimate data is available.
Unable to determine if TerrAscend is high growth as no revenue estimate data is available.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can
be gauged below. We look back 3 years and see if they were any good at
predicting what actually occurred. We also show the highest and lowest estimates
looking forward to see if there is a wide range.
TerrAscend's performance over the past 5 years by checking for:
Has earnings increased in past 5 years? (1 check)
Has the earnings growth in the last year exceeded that of the
industry? (1 check)
Is the recent earnings growth over the last year higher than the average annual growth over the
past 5 years? (1 check)
Is the Return on Equity (ROE) higher than 20%? (1 check)
Is the Return on Assets (ROA) above industry average? (1 check)
Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent
earnings report. Some checks require at least 3 or 5 years worth of data.
has a total score of
0/6, see the detailed checks below.
Note: We use GAAP Net Income excluding extraordinary items in all our calculations.
Management is one of the most important areas of a company. We look at
unreasonable CEO compensation, how long the team and board of directors have
been around for and insider trading.
TENURE AS CEO
Dr. Michael Nashat is Co-Owner of Star-Pharma Pan-America Inc. Dr. Nashat serves as the Chief Executive Officer, Co-Founder and Director at TerrAscend Corp. since June 2019 and also served as the Chief Executive Officer since January 22, 2018 until June 2019. He served as Chief Operating Officer of Solace Health Inc. Dr. Nashat is Co-Founder of TerrAscend Corp. and serves as its Chief Operating Officer and Executive Vice President since 2017 until June 2019. Dr. Nashat serves as Executive Director for OnPharm Independent Pharmacy Group, which represents the commercial interest of over 340 pharmacies. He served as President of TerrAscend Corp. since January 22, 2018 until November 29, 2018. He serves as the Co-chair of the Ontario pharmacy owners advisory council and was a former member of the Ontario Ministry of Health and Long Term Care's Pharmacy Council. Dr. Nashat has been a Director of TerrAscend Corp. since March 7,2017. He serves as a Director of Solace Health Inc. He is a former board member for the Ontario College of Pharmacists, Canadian Foundation for pharmacy and the Canadian Association of Chain Drug Stores. Dr. Nashat received his Doctor of Pharmacy from the Albany College of Pharmacy and Health Science and completed his Post-Doctoral Fellowship in Neuroscience Medical Strategy at Bristol Myers Squibb/Rutgers University in New Jersey, U.S.
Michael's compensation has increased whilst company is loss making.
Michael's remuneration is lower than average for companies of similar size in Canada.
Management Team Tenure
Average tenure of the
management team in years:
The average tenure for the TerrAscend management team is less than 2 years, this suggests a new team.
CEO, Co-Founder & Director
Chief Financial Officer
Director of Marketing
Board of Directors Tenure
Average tenure and age of the
board of directors in years:
The average tenure for the TerrAscend board of directors is less than 3 years, this suggests a new board.
Board of Directors
Chairman of the Board
CEO, Co-Founder & Director
Who owns this company?
Recent Insider Trading
No 3 month open market individual insider trading information.
Need To Know: TerrAscend Corp. (CNSX:TER) Insiders Have Been Buying Shares
So we'll take a look at whether insiders have been buying or selling shares in TerrAscend Corp. … In the last twelve months TerrAscend insiders were buying shares, but not selling. … CNSX:TER Recent Insider Trading, September 4th 2019 Are TerrAscend Insiders Buying Or Selling?
The TerrAscend Share Price Has Gained 154%, So Why Not Pay It Some Attention?
We'll need to follow TerrAscend for a while to get a better sense of its share price trend, since it hasn't been listed for particularly long. … TerrAscend isn't a profitable company, so it is unlikely we'll see a strong correlation between its share price and its earnings per share (EPS). … When a company doesn't yet make profits, we'd generally expect to see good revenue growth.
What Kind Of Shareholder Owns Most TerrAscend Corp (CNSX:TER) Stock?
A look at the shareholders of TerrAscend Corp (CNSX:TER) can tell us which group is most powerful. … So it's nice to see some insider ownership, because it may suggest that management is owner-oriented. … Taking a look at the our data on the ownership groups (below), it's seems that.
In this analysis, my focus will be on developing a perspective on TerrAscend Corp’s (CNSX:TER) latest ownership structure, a less discussed, but important factor. … The impact of a company's ownership structure affects both its short- and long-term performance. … The effect of an active institutional investor with a similar ownership as a passive pension-fund can be vastly different on a company's corporate governance and accountability to shareholders.
TerrAscend Corp. engages in the cultivation and sale of medical and adult use cannabis in Canada. The company offers its cannabis products under the Knüba Naturals brand. It also provides education and support programs to physicians and patients through health care professionals. The company was incorporated in 2017 and is headquartered in Mississauga, Canada.
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.